TechFlow Secures 7-Year $2.1 Billion TSA Contract for Explosives Detection System Upkeep at Over 300 Facilities Spanning the U.S. and its Territories
07 déc. 2023 08h00 HE
|
TechFlow, Inc.
TechFlow Secures 7-Year $2.1 Billion TSA Contract for Explosives Detection System Upkeep at Over 300 Facilities Spanning the U.S. and its Territories
Axsome Therapeutics Announces Sunosi® (Solriamfetol) Meets Primary Endpoint Demonstrating Improvement in Cognitive Function in the SHARP Trial in Cognitively Impaired Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea
03 oct. 2022 06h30 HE
|
Axsome Therapeutics, Inc.
Statistically significant improvement in cognitive function, as measured by the DSST RBANS compared to placebo (p=0.009, primary endpoint) Statistically significant patient-reported improvement in...
Axsome Therapeutics Announces Publication of Post-hoc Analysis of Sunosi® Effect on Excessive Daytime Sleepiness in Narcolepsy or Obstructive Sleep Apnea Patients with a History of Depression in the Journal of Psychiatric Research
07 sept. 2022 07h00 HE
|
Axsome Therapeutics, Inc.
NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Axsome Therapeutics Hosts Sunosi® Investor Update Virtual Event Today with Key Opinion Leaders
28 juin 2022 07h00 HE
|
Axsome Therapeutics, Inc.
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Axsome Therapeutics to Host Sunosi® Investor Update Virtual Event
22 juin 2022 07h00 HE
|
Axsome Therapeutics, Inc.
NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience
28 mars 2022 06h00 HE
|
Axsome Therapeutics, Inc.
Sunosi is the first and only dual-acting dopamine and norepinephrine reuptake inhibitor (DNRI) approved by the FDA to improve wakefulness in adults living with excessive daytime sleepiness associated...
AVX to Attend & Announce New Products at EDS 2015
28 avr. 2015 13h22 HE
|
AVX Corporation
GREENVILLE, S.C., April 28, 2015 (GLOBE NEWSWIRE) -- AVX Corporation, a leading manufacturer of passive components and interconnect solutions, is attending the 2015 Electronic Distribution Show (EDS),...
AVX & AVNET CELEBRATE 50 YEARS OF SUCCESS
05 août 2013 16h51 HE
|
AVX Corporation
GREENVILLE, S.C., Aug. 5, 2013 (GLOBE NEWSWIRE) -- AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has become the first passive supplier to celebrate a...
Omron Electronic Components Announces 2012 Supplier Business Manager of the Year
03 juin 2012 23h46 HE
|
Omron Electronic Components, LLC
SCHAUMBURG, IL--(Marketwire - Jun 3, 2012) - Omron Electronic Components presented Mr. Jason Shaw of Arrow Electronics with the 2012 Supplier Business Management of the Year award at the annual...
Omron Presents 2012 Award to TTI for Their Superior Electromechanical Segment Focus
03 juin 2012 23h39 HE
|
Omron Electronic Components, LLC
SCHAUMBURG, IL--(Marketwire - Jun 3, 2012) - Omron Electronic Components LLC presented TTI with the 2012 Electromechanical Segment Focus Award, at the Electronics Distribution Show in Las Vegas....